Clinical Trial Update: Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ropivacaine 0.2% with dexamethasone versus ropivacaine 0.2% with placebo in modified pectoral block for breast pain relief.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia Local
• Breast Pain

Drugs mentioned

• ropivacaine 0.2% + dexamethasone (ropivacaine)
• ropivacaine 0.2% + placebo (ropivacaine)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Effect of Drugs, Breast Pain | Phase 4 | Status: UNKNOWN